| abstract |
Disclosed is a composition comprising an anti-CD83 agonist antibody. A method for treating an autoimmune disease (such as inflammatory bowel disease) with an anti-CD83 agonist antibody, and a product comprising the anti-CD83 agonist antibody. Autoimmune diseases include rheumatoid arthritis, juvenile rheumatoid arthritis, systemic lupus erythematosus (SLE), lupus nephritis, ulcerative colitis, Wegener's disease, inflammatory bowel disease, idiopathic thrombocytopenic purpura ( ITP), thrombotic thrombocytopenic purpura (TTP), autoimmune thrombocytopenia, multiple sclerosis, psoriasis, IgA nephropathy, IgM neuropathy, myasthenia gravis, vasculitis, diabetes, Raynaud's syndrome, Sjogren Selected from the group consisting of syndrome and glomerulonephritis. [Selection figure] None |